儿童MOGAD在重症监护病房:病例系列
本研究为单中心回顾性病例系列,纳入2017年1月至2024年12月期间在某大型儿童三级医疗中心确诊的124例儿童MOGAD患者,其中37例因意识改变、癫痫发作和/或快速起病的肌无力需入住ICU。在ICU患者中,16例因意识改变或癫痫发作行气管插管,中位插管时长3天(IQR 2-10.8天);发热常见(24例);7例接受ICP导向的高渗治疗,2例放置ICP监测装置;12例神经影像学提示颅内压增高,其中4例存在脑疝或脑中线移位;18例出现癫痫发作,11例为癫痫持续状态;27例接受cEEG监测,背景模式异质性大。结论提示严重MOGAD表现日益被认识,预见并处理癫痫持续状态或颅内压增高等并发症可能预防继发性脑损伤,本队列未观察到MOGAD特异性EEG生物标志物。
要点
- 12例神经影像学提示颅内压增高,其中4例存在脑疝或脑中线移位;7例接受ICP导向的高渗治疗,2例放置ICP监测装置。
- 发热在ICU患者中常见(24/37),需注意与感染或疾病活动鉴别。
适用人群与场景
- 儿童MOGAD患者,因意识改变、癫痫发作和/或快速起病的肌无力需入住ICU者;研究场景为大型儿童三级医疗中心,非院前。
诊断标准与关键阈值
- 原文未提及MOGAD诊断标准的具体条件或界值。
- 原文未提及ICU入住的具体评分或阈值,入住指征为意识改变、癫痫发作和/或快速起病的肌无力。
处置流程与药物剂量
- 对因意识改变或癫痫发作的ICU患儿应考虑气管插管,本队列16例插管,中位时长3天(IQR 2-10.8天)。
- 对怀疑颅内压增高者可行ICP导向的高渗治疗(7例)或放置ICP监测装置(2例),具体药物、剂量及目标值原文未提及。
- 对癫痫发作患者应行cEEG监测(27例),癫痫持续状态(11例)的处理方案原文未提及。
- 发热常见(24例),需评估并处理,原文未提及具体退热或抗感染方案。
红旗征与不能漏的情况
- 癫痫持续状态:11例出现,需紧急处理,原文未提及具体处理方案。
- 颅内压增高:12例神经影像学提示,其中4例存在脑疝或脑中线移位,需紧急干预(高渗治疗或ICP监测),原文未提及具体药物剂量及目标值。
- 意识改变或癫痫发作需气管插管:16例,提示需准备气道管理。
研究设计与关键结果
- 研究类型:单中心回顾性病例系列;样本量:124例儿童MOGAD,其中37例需ICU入住;中心数:1个大型儿童三级医疗中心。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:单中心回顾性病例系列;原文未给出证据等级或推荐强度。
- 局限:回顾性设计、单中心、样本量较小(ICU患者37例),原文未提及盲法或对照。
对床旁实践的改变
- 对儿童MOGAD患者应警惕重症可能,意识改变、癫痫发作或快速起病的肌无力是ICU入住指征。
- 对ICU内MOGAD患儿应积极监测癫痫发作(cEEG)和颅内压增高征象,必要时行高渗治疗或ICP监测,以预防继发性脑损伤。
- 发热常见,需评估原因并处理;原文未提及具体方案。
- 原文未提及MOGAD特异性EEG生物标志物,cEEG背景模式异质性大,不应依赖EEG标志物诊断。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is an antibody mediated demyelinating disorder of the central nervous system with a spectrum of clinical presentations and severity, including a subgroup of patients requiring admission to an intensive care unit (ICU) due to severity of their disease. While there is a growing body of literature on MOGAD, there are limited reports focusing on patients requiring admission to an ICU. The aim of this study was to better characterize a population of pediatric patients with MOGAD with critical illness, focusing on patients requiring ICU admission.
METHODS: A retrospective chart review was performed on pediatric patients with MOGAD between January 2017 and December 2024 at a large pediatric tertiary care center. Clinical, laboratory, and imaging data were collected for all patients with MOGAD. Magnetic resonance neuroimaging was reviewed by a board-certified pediatric neuroradiologist.
RESULTS: Of the 124 pediatric patients with MOGAD identified, 37 required ICU admission for either altered mental status, seizures, and/or rapid onset of weakness. Of those requiring ICU admission, 16 were intubated due to altered mental status or seizures for a median duration of 3 days (IQR 2-10.8 days). Fever was common, present in 24 of the patients in the ICU. Seven patients received intracranial pressure (ICP)-directed hyperosmolar therapy, and two patients had an ICP monitoring device placed. In total, 12 patients had neuroimaging evidence of increased ICP, with 4 of these having evidence of herniation or cerebral shift. Seizures were present in 18 patients, and 11 patients had status epilepticus. There were 27 patients who had continuous electroencephalography (cEEG) monitoring with a heterogeneity of background patterns observed.
CONCLUSIONS: Severe presentations of MOGAD are increasingly recognized, including patients with a clinical course complicated by status epilepticus or increased ICP. Anticipating and addressing these complications may prevent secondary cerebral injury. No specific EEG biomarkers for MOGAD were observed in our cohort.
参考来源
- Runco AD, Davila-Williams D, Moeller KK, et al. Pediatric MOGAD in the Intensive Care Unit: A Case Series. Neurocrit Care. 2026. PMID: 42768270. doi:10.1007/s12028-026-02653-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。